Results 221 to 230 of about 399,116 (301)

KAT2A: a prognostic biomarker influencing proliferation and immune escape in lung adenocarcinoma. [PDF]

BMC Cancer
Ke Z, Xu H, Shen K, Wen Y, Pan X, Qian Z, Wang L, Zhu S, Wan B, Song Y.   +9 more
europepmc   +1 more source

Clinical Spectrum and Outcomes of SOX1 Antibody‐Associated Paraneoplastic Neurological Syndromes: A Chinese Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background SOX1 antibody‐positive paraneoplastic neurological syndromes (PNS) exhibit significant population‐specific clinical heterogeneity. While Western cohorts predominantly manifest Lambert‐Eaton myasthenic syndrome (65%–80%), comprehensive clinical characterization and treatment response data in Asian populations remain critically ...
Jin‐Long Ye, Zu‐Ying Kuang, Bo Li, Meng‐Qiu Pan, Li‐Hua Zhou, Yang‐Yang Dai, Si‐Fen Xie, Xian‐Guang Lin, Ye‐Peng Hu, Li‐Hong Jiang, Zhan‐Hang Wang, Wei‐Jing Zhang   +11 more
wiley   +1 more source

A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer. [PDF]

Cancer Immunol Immunother
Saif MSI, Sehgal K, Zhang Z, Butler RA, Wiencke JK, Molinaro AM, Miller J, Stolrow HG, Shirai K, Salas LA, Koestler DC, Haddad R, Christensen BC, Kelsey KT.   +13 more
europepmc   +1 more source

Clinically Relevant Outcome Measures in Women With Adrenoleukodystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Adrenoleukodystrophy is a rare inherited peroxisomal disease caused by pathogenic variants in the ABCD1 gene located on the X chromosome. Although the most severe central nervous system and adrenal complications typically affect only men with adrenoleukodystrophy, the majority of women develop myeloneuropathy symptoms in adulthood.
Chenwei Yan, Elizabeth I. Pierpont, Amena S. Fine, Reena V. Kartha   +3 more
wiley   +1 more source

HCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer. [PDF]

Int J Breast Cancer
Bellah SF, Hossen MA, Billah SMS, Islam MN.   +3 more
europepmc   +1 more source

Clustering Algorithm Reveals Dopamine‐Motor Mismatch in Cognitively Preserved Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore the relationship between dopaminergic denervation and motor impairment in two de novo Parkinson's disease (PD) cohorts. Methods n = 249 PD patients from Parkinson's Progression Markers Initiative (PPMI) and n = 84 from an external clinical cohort.
Rachele Malito, Chiara Meneghini, Alice Galli, Luca Gallo, Pierfrancesco Mitrotti, Paola Dimartino, Marianna Inglese, Cinzia Zatti, Alessandro Lupini, Andrea Pilotto, Alessandro Padovani, Micol Avenali, Enza Maria Valente, Cristina Tassorelli, Silvia P. Caminiti   +14 more
wiley   +1 more source

KELIM PSA as a Prognostic Biomarker in Castration-Resistant Prostate Cancer Treated with ARPI. [PDF]

J Clin Med
Atalah F, Kuş F, Acarbay A, Karakök A, Alkan O, Nazlı İ, Özilice U, Beşiroğlu M, Gümüş M.   +8 more
europepmc   +1 more source

Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory [PDF]

, 2018
et al,, Fagan, Anne M, Jerome, Gina
core   +1 more source

Diffusion Spectrum Imaging Maps Early Axonal Loss and a Unique Progressive Signal in Neuronal Intranuclear Inclusion Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To delineate specific in vivo white matter pathology in neuronal intranuclear inclusion disease (NIID) using diffusion spectrum imaging (DSI) and define its clinical relevance. Methods DSI was performed on 42 NIID patients and 38 matched controls.
Kaiyan Jiang, Yixiu Pei, Xiaobao Hu, Ying Xiong, Fang Wang, Yanyan Yu, Min Zhu, Dandan Tan, Meihong Zhou, Daojun Hong, Fuqing Zhou   +10 more
wiley   +1 more source

Exploring the pentraxin-3 as a prognostic biomarker in paraquat poisoning: a systematic-narrative hybrid review. [PDF]

Int J Emerg Med
Mathew D, Patra AP.
europepmc   +1 more source